FindTrial
Sign In

A phase 2 study of K-134 in patients with peripheral arterial disease

A phase 2 study of K-134 in patients with peripheral arterial disease

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080220838
Enrollment
Unknown
Registered
2009-09-02
Start date
2009-09-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral arterial disease

Interventions

investigational material(s) Generic name etc : K-134 INN of investigational material : Therapeutic category code : 217 Vasodilators Dosage and Administration for Investigational material : Oral cont

Sponsors

Kowa Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Peripheral arterial disease

Exclusion criteria

Exclusion criteria: Patients with critical limb ischemia

Design outcomes

Primary

MeasureTime frame
Efficacy and Safety—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026